A team including Matthias Mann has developed a spatial proteomics workflow that maps which proteins are selectively concentrated in the α-synuclein inclusions characteristic of Parkinson’s disease – offering clues to how these structures form and their potential role in neuronal dysfunction.
The approach, called Aggregate Deep Visual Proteomics, combines image-guided segmentation, laser microdissection, low-input sample preparation, and liquid chromatography-tandem mass spectrometry. Researchers applied it to a cell model, induced pluripotent stem cell-derived dopaminergic neurons, and postmortem brain tissue from people with Parkinson’s disease or Lewy body disease.
The findings were reported in a bioRxiv preprint.
Previous proteomic studies have cataloged proteins found in Lewy pathology, but detecting a protein within an inclusion does not establish whether it is selectively concentrated there or simply reflects the surrounding cell. Aggregate Deep Visual Proteomics addresses this problem by comparing inclusion material with a matched host fraction from the same sample.
Researchers stained pathological inclusions for α-synuclein phosphorylated at serine 129, computationally segmented the images, and isolated selected regions by automated laser microdissection. Compact inclusions measuring approximately 50 to 100 square micrometers could be excised whole, with the system processing up to about 1,000 shapes per hour.
In HEK293 cells expressing A53T α-synuclein, the team quantified 7,290 proteins. Enrichment within inclusions was largely independent of a protein’s abundance in the cell, indicating that the aggregates did not capture cellular proteins randomly.
Analysis of dopaminergic neurons quantified 6,444 proteins and identified different profiles in neuritic and somatic inclusions. Neuritic inclusions were enriched in machinery associated with misfolded and ubiquitinated proteins, including a sevenfold increase in UBQLN2. Somatic inclusions contained more intermediate filaments, membrane transporters, and dense-core vesicle proteins.
The researchers also examined formalin-fixed, paraffin-embedded brain tissue from 16 donors across discovery and replication cohorts. Proteomic analysis quantified 6,842 protein groups. Round, Lewy body-like inclusions were enriched in synaptic-vesicle proteins, SNARE machinery, and V-ATPase components compared with matched host neurons. Membrane and vesicle proteins were proportionally more abundant in the inclusions across all disease donors.
Across the three experimental systems, protein-complex subunits generally moved together: 421 of 438 evaluated complexes showed coordinated inclusion enrichment or depletion. The V-ATPase was the only complete molecular machine enriched in all three systems.
An additional phosphoproteomic analysis detected 4,622 localized phosphorylation sites in the cell model. Phosphorylated α-synuclein was approximately tenfold more abundant in inclusions than in the remaining cell material, although about one-third of the increase was already detectable before visible inclusions formed.
The study supports a model in which α-synuclein inclusions selectively sequester membrane-associated machinery and retain cargo linked to impaired degradation. However, the human cohort was small, patients represented a single Lewy body stage, and the workflow did not resolve finer histopathological subtypes.
